Artwork

Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Amneal's Parkinson's pill approved, Novo Nordisk withdraws Wegovy approval expansion bid, FDA delays BeiGene Tevimbra decision [The good, the bad, the ugly]

2:59
 
Share
 

Manage episode 433875456 series 2941835
Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.

Up this week:

The good — Amneal gets FDA nod for Parkinson’s pill

The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure

The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy

  continue reading

64 episodes

Artwork
iconShare
 
Manage episode 433875456 series 2941835
Content provided by Pharma Manufacturing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pharma Manufacturing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly.

Up this week:

The good — Amneal gets FDA nod for Parkinson’s pill

The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure

The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy

  continue reading

64 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide